CellaVision's products are an integral final step in the blood analysis chain. Therefore, the company cooperates on sales and distribution with leading global manufacturers of cell counters. This indirect sales model means that CellaVision has access to a far greater sales force than the company could build up by itself. At the same time, the model puts high requirements on CellaVision's ability to provide professional support to both partners and customers.
Part of this work is CellaVision's expansion of local market support organizations. The possibility of supporting the company's distributors on site is crucial to utilizing the opportunities offered by the market. In addition to supporting CellaVision's various partners locally, CellaVision's local organizations develop the networks with end customers, which provides important information about the market in order to be able to drive penetration and sales via the indirect business model, and also provide insight into the end-user's needs, which is of great importance for future product development.
At this moment CellaVision is represented in 18 countries:
- Sweden
- Australia
- Brazil
- Canada
- China
- West China
- DACH
- France
- USA
- India
- Italy
- Japan
- UAE
- Mexico
- South East Asia
- Korea
- Spain
- United Kingdom/Ireland
